Загрузка...
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
INTRODUCTION: Lung cancer is the leading cause of cancer-related mortality. Platinum-based chemotherapy is the usual first-line treatment for advanced nonsmall cell lung cancer (NSCLC), although an efficacy plateau has been reached with this approach. Bevacizumab is a recombinant, humanized, monoclo...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2007
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3012552/ https://ncbi.nlm.nih.gov/pubmed/21221196 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|